Polyrizon Ltd. announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (SEC). The report provides detailed financial and operational information for the past year.
For 2024, Polyrizon reported zero revenue, consistent with its development-stage status, and a net loss of $1.54 million, an increase from $600,000 in 2023. Research and Development expenses rose to $534,000 in 2024 from $332,000 in 2023, reflecting increased pipeline investment. Selling, General, and Administrative expenses also increased to $768,000 from $303,000 in 2023.
Despite ongoing losses, the company significantly improved its liquidity, with cash and cash equivalents surging to $2.55 million in 2024 from $4,000 in 2023, primarily due to capital stock issuance. Working capital turned positive to $2.39 million, and the current ratio stood at 44.04, indicating a stronger financial foundation for future development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.